ProCE Banner Activity

Expert Insights Into HER2 Testing for Advanced Breast, GI, and Lung Cancers


Download this slideset for expert perspectives and guideline recommendations on HER2 testing to inform targeted therapy for patients with advanced breast, gastroesophageal, colorectal, and lung cancers. 

Released: March 25, 2024

Expiration: March 24, 2025



Laura C. Collins

Laura C. Collins, MD

Vice Chair of Anatomic Pathology
Director of Breast Pathology
Beth Israel Deaconess Medical Center
Professor of Pathology
Harvard Medical School
Boston, Massachusetts

Alexander Craig Mackinnon, Jr.

Alexander Craig Mackinnon, Jr., MD, PhD, MSHA

Robert B. Adams Endowed Professor
Professor and Director, Division of Genomic Diagnostics & Bioinformatics
Department of Pathology
The University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Elizabeth D. Thompson

Elizabeth D. Thompson, MD, PhD

Associate Professor of Pathology and Oncology
Division of Surgical Pathology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, and Seagen.


Daiichi Sankyo, Inc.

Jazz Pharmaceuticals